SCHEMBL340846

SCHEMBL340846

CCOC(=O)[C@@H](N)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 1/20 0.56
PIN1 Q13526 1/20 0.51
KMT2A Q03164 2/20 0.50
MEN1 O00255 1/20 0.50
NPC1 O15118 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.49
TSHR P16473 2/20 0.47
GAA P10253 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
PKM P14618 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA9 Q16790 1/20 0.46
SLC6A2 P23975 1/20 0.46
SLC6A4 P31645 1/20 0.46
SLC6A3 Q01959 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL280229 1.00 MMP8 (0.56) MMP8PIN1KMT2AMEN1NPC1
SCHEMBL8129701 1.00 MMP8 (0.56) MMP8PIN1KMT2AMEN1NPC1
Hydrochloric Acid SCHEMBL1630960 0.98 PIN1 (0.54) MMP8PIN1KMT2AMEN1NPC1
Hydrochloric Acid SCHEMBL28989563 0.98 PIN1 (0.54) MMP8PIN1KMT2AMEN1NPC1
Hydrochloric Acid SCHEMBL1851016 0.98 PIN1 (0.54) MMP8PIN1KMT2AMEN1NPC1
SCHEMBL10599023 0.90 KCNH2 (0.44) MMP8PIN1KMT2AMEN1NPC1
SCHEMBL7788579 0.87 MMP8 (0.46) MMP8PIN1KMT2AMEN1NPC1
SCHEMBL31059195 0.87 NPC1 (0.54) MMP8PIN1NPC1SMN1; SMN2TDP1
SCHEMBL9667155 0.87 MEN1 (0.50) MMP8PIN1KMT2AMEN1NPC1
SCHEMBL31556288 0.85 LMNA (0.53) MMP8KMT2ANPC1SMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119977826-A Rotigotine intermediate and preparation method and application thereof 烟台药物研究所 2025-05-13 CN claimed
CN-119977826-A Rotigotine intermediate and preparation method and application thereof 烟台药物研究所 2025-05-13 CN disclosed
EP-3015488-B1 PRODUCTION METHOD FOR POLYAMINO ACID TAKEDA PHARMACEUTICALS CO (JP) 2024-03-06 EP disclosed
US-10336864-B2 Production method for poly(amino acid) TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2019-07-02 US disclosed
CN-105492494-B The manufacturing method of polyaminoacid 武田药品工业株式会社 2018-05-22 CN disclosed
US-20180044472-A1 PRODUCTION METHOD FOR POLY(AMINO ACID) TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-02-15 US disclosed
US-9815938-B2 Production method for poly(amino acid) TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2017-11-14 US disclosed
US-20160177032-A1 PRODUCTION METHOD FOR POLY(AMINO ACID) TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-23 US disclosed
EP-3015488-A1 PRODUCTION METHOD FOR POLYAMINO ACID Takeda Pharmaceutical Company Limited (JP) 2016-05-04 EP disclosed
CN-105492494-A Production method for polyamino acid TAKEDA PHARMACEUTICALS CO 2016-04-13 CN disclosed
US-20120016151-A1 PROCESS FOR MANUFACTURE AND RESOLUTION OF 2-ACYLAMINO-3-DIPHENYLPROPANOIC ACID NOVARTIS AG (CH) 2012-01-19 US disclosed
EP-2387558-A1 PROCESS FOR MANUFACTURE AND RESOLUTION OF 2-ACYLAMINO-3-DIPHENYLPROPANOIC ACID Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (CN) 2011-11-23 EP disclosed
US-20110253230-A1 Temperature Sensitive Valve Having Shape Memory Actuator OMNITEK PARTNERS LLC (US) 2011-10-20 US disclosed
WO-2010081410-A1 PROCESS FOR MANUFACTURE AND RESOLUTION OF 2-ACYLAMINO-3-DIPHENYLPROPANOIC ACID ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD. (CN) 2010-07-22 WO disclosed
WO-2006111549-A1 DIHYDROTHIENOPYRIMIDINES FOR THE TREATMENT OF INFLAMMATORY DISEASES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-10-26 WO disclosed
EP-0625507-B1 Urea derivatives and their use as acat inhibitors NISSHIN FLOUR MILLING CO (JP) 1997-07-23 EP disclosed
US-5621010-A ANTIHYPERCHOLESTEROLEMIA AND ANTIATHEROSCLEROSIS NISSHIN FLOUR MILLING CO., LTD. (JP) 1997-04-15 US disclosed
EP-0625507-A2 Urea derivatives and their use as acat inhibitors NISSHIN FLOUR MILLING CO., LTD. (JP) 1994-11-23 EP disclosed
US-5175159-A Prevention of premature labor MERCK & CO., INC. (US) 1992-12-29 US disclosed
US-4260684-A Stereoselective resolution of phenylglycine derivatives and 4-hydroxyphenylglycine derivatives with enzyme resins BAYER AKTIENGESELLSCHAFT (DE) 1981-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120016151-A1 PROCESS FOR MANUFACTURE AND RESOLUTION OF 2-ACYLAMINO-3-DIPHENYLPROPANOIC ACID DNPEP, MME, DPP7 MMP8 803/4885PIN1 1441/4885KMT2A 2149/4885
US-20180044472-A1 PRODUCTION METHOD FOR POLY(AMINO ACID) PGA5, ENPEP, PARG MMP8 4693/4885PIN1 638/4885KMT2A 1628/4885
US-10336864-B2 Production method for poly(amino acid) PGA5, ENPEP, PARG MMP8 4693/4885PIN1 638/4885KMT2A 1628/4885
US-20160177032-A1 PRODUCTION METHOD FOR POLY(AMINO ACID) PGA5, ENPEP, PARG MMP8 4693/4885PIN1 638/4885KMT2A 1628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.